Daniel O’Connell, M.D., Ph.D.
Daniel O’Connell, M.D., Ph.D. has served as a member of LogicBio’s board of directors since June 2017. Dr. O’Connell has served as an investment director at Arix Bioscience, a healthcare and life science company, since October 2016. Previously, Dr. O’Connell served as an associate at OrbiMed Advisors, a healthcare investment firm. He has served as a director of PreciThera, Inc., since July 2017. Dr. O’Connell holds an S.B. in both chemistry and mathematics from MIT and an M.D. and Ph.D. from Tufts University.